Transcat, Inc. (NASDAQ:TRNS) Shares Acquired by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC boosted its position in Transcat, Inc. (NASDAQ:TRNS) by 40.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 35,685 shares of the scientific and technical instruments company’s stock after acquiring an additional 10,238 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Transcat were worth $3,773,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in TRNS. Conestoga Capital Advisors LLC lifted its holdings in Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after buying an additional 137,830 shares in the last quarter. Champlain Investment Partners LLC lifted its holdings in Transcat by 22.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after buying an additional 74,169 shares in the last quarter. Royce & Associates LP lifted its holdings in Transcat by 8.2% in the 3rd quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock worth $61,798,000 after buying an additional 38,774 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after buying an additional 17,743 shares in the last quarter. Finally, State Street Corp lifted its holdings in Transcat by 8.1% in the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after buying an additional 15,514 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Insider Activity at Transcat

In other Transcat news, Director Craig D. Cairns acquired 1,200 shares of the stock in a transaction that occurred on Friday, January 31st. The stock was acquired at an average price of $77.02 per share, with a total value of $92,424.00. Following the transaction, the director now directly owns 1,910 shares in the company, valued at approximately $147,108.20. This represents a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.30% of the company’s stock.

Transcat Price Performance

Shares of NASDAQ:TRNS opened at $82.41 on Wednesday. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. Transcat, Inc. has a fifty-two week low of $73.37 and a fifty-two week high of $147.12. The firm has a 50-day simple moving average of $97.20 and a 200 day simple moving average of $109.58. The company has a market cap of $767.24 million, a PE ratio of 44.55 and a beta of 0.67.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter in the prior year, the firm posted $0.56 earnings per share. On average, sell-side analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on TRNS. Craig Hallum boosted their price objective on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Oppenheimer lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. HC Wainwright cut their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, February 5th. Finally, Northland Securities restated a “market perform” rating and issued a $85.00 target price (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $111.50.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.